Availability of mesalazine (5-aminosalicylic acid) from enemas and suppositories during steady-state conditions.
暂无分享,去创建一个
S. Hansen | L. A. Christensen | H. Rasmussen | J. Fallingborg | B. Jacobsen | S. Rasmussen | K. Abildgaard | L. Christensen | H. Rasmussen
[1] S. Hansen,et al. Topical and systemic availability of 5‐amino‐salicylate: comparisons of three controlled release preparations in man , 1990, Alimentary pharmacology & therapeutics.
[2] G. Porro,et al. Mesalazine (5-aminosalicylic acid) suppositories in the treatment of ulcerative proctitis or distal proctosigmoiditis. A randomized controlled trial. , 1990, Scandinavian journal of gastroenterology.
[3] L. Sutherland. Topical treatment of ulcerative colitis. , 1990, The Medical clinics of North America.
[4] B. Norlander,et al. Pharmacokinetics of a 5‐aminosalicylic acid enteric‐coated tablet and suppository dosage form , 1989, Alimentary pharmacology & therapeutics.
[5] G. Tytgat,et al. Comparison of 5-aminosalicylic acid (3 g) and prednisolone phosphate sodium enemas (30 mg) in the treatment of distal ulcerative colitis. A prospective, randomized, double-blind trial. , 1988, Scandinavian journal of gastroenterology.
[6] P. Wesseling,et al. Double‐blind comparison of 5‐aminosalicylic acid and acetyl‐5‐aminosalicylic acid suppositories in patients with idiopathic proctitis , 1988, Alimentary pharmacology & therapeutics.
[7] L. Sutherland,et al. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. , 1987, Gastroenterology.
[8] P. Gionchetti,et al. Retrograde spread of 5-aminosalicylic acid enemas in patients with active ulcerative colitis , 1986, Diseases of the colon and rectum.
[9] G. Labó,et al. Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. , 1985, Gut.
[10] S. Hansen,et al. 5-Aminosalicylic acid enemas in patients with active ulcerative colitis. Influence of acidity on the kinetic pattern. , 1984, Scandinavian journal of gastroenterology.
[11] J. Rhodes,et al. 5‐Aminosalicylic acid in serum and urine after administration by enema to patients with colitis , 1983, The Journal of pharmacy and pharmacology.
[12] S. Hansen. Assay of 5-aminosalicylate and its acetylated metabolite in biological fluids by high-performance liquid chromatography on dynamically modified silica. , 1981, Journal of chromatography.
[13] G. Labó,et al. TREATMENT OF ULCERATIVE COLITIS WITH HIGH-DOSE 5-AMINOSALICYLIC ACID ENEMAS , 1981, The Lancet.
[14] J. V. van Tongeren,et al. Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. , 1980, Gut.
[15] S. Truelove,et al. AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE , 1977, The Lancet.
[16] Thomas We,et al. Enteric fever apparently spread by pasteurized milk. , 1948 .